Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years
一项针对18-70岁成年人的灭活SARS-CoV-2疫苗FAKHRAVAC的安全性和免疫原性的II期随机、双盲、安慰剂对照临床试验
期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-023-08079-1
Gholami, Fatemeh; Hamidi Farahani, Ramin; Karimi Rahjerdi, Ahmad; Ahi, Mohammadreza; Sheidaei, Ali; Gohari, Kimiya; Rahimi, Zahra; Ansarifar, Akram; Basiri, Pouria; Moradi, Milad; Jahangiri, Arash; Naderi, Kosar; Ghasemi, Soheil; Khatami, Pezhman; Honari, Mohsen; Khodaverdloo, Samane; Shooshtari, Mohammad; Mehr Azin, Hajar; Moradi, Sohrab; Shafaghi, Batool; Allahyari, Hossein; Monazah, Arina; Khodaei Poor, Ali; Taghva, Zahra; Bakhshande, Hooman; Karimi Nia, Mohammad; Solaymani Dodaran, Masoud; Forooghizade, Mohsen
